Measurement of tumor size in adult glioblastoma: Classical cross-sectional criteria on 2D MRI or volumetric criteria on high resolution 3D MRI?

European Journal of Radiology

Volumn 81, Issue 9, 2012, Pages 2370-2374

  Wang, Mei Yun ^a   Cheng, Jing Liang ^b   Han, Yan Hong ^a   Li, Yong Li ^a   Dai, Jian Ping ^a   Shi, Da Peng ^a  

^a HENAN PROVINCIAL PEOPLE'S HOSPITAL   (China)

^b THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

Author keywords

Comparative study; Glioblastoma; Magnetic resonance imaging; Photogrammetry; Tumor response

Indexed keywords

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER SIZE; CLINICAL ARTICLE; FEMALE; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; IMAGE QUALITY; INTERMETHOD COMPARISON; MALE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; THREE DIMENSIONAL IMAGING; TWO DIMENSIONAL IMAGING; VOLUMETRY;

ADULT; AGED; AGED, 80 AND OVER; ALGORITHMS; BRAIN NEOPLASMS; FEMALE; GLIOBLASTOMA; HUMANS; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; IMAGING, THREE-DIMENSIONAL; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

EID: 84864692965     PISSN: 0720048X     EISSN: 18727727     Source Type: Journal    
DOI: 10.1016/j.ejrad.2011.05.017     Document Type: Article

References (30)

1. D.R. Macdonald, T.L. Cascino, S.C. Schold Jr., and J.G. Cairncross Response criteria for phase II studies of supratentorial malignant glioma J Clin Oncol 8 1990 1277 1280
2. D.F. Yankelevitz, A.P. Reeves, W.J. Kostis, B. Zhao, and C.I. Henschke Small pulmonary nodules: volumetrically determined growth rates based on CT evaluation Radiology 217 2000 251 256
3. A.G. Sorensen, S. Patel, and C. Harmath Comparison of diameter and perimeter methods for tumor volume calculation J Clin Oncol 19 2001 551 557
4. T.T. Batchelor, A.G. Sorensen, and E. di Tomaso AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients Cancer cell 11 2007 83 95
5. K. James, E. Eisenhauer, and M. Christian Measuring response in solid tumors: unidimensional versus bidimensional measurement J Natl Cancer Inst 91 1999 523 528
6. M.F. Dempsey, B.R. Condon, and D.M. Hadley Measurement of tumor "size" in recurrent malignant glioma: 1D, cross-sectional, or volumetric? AJNR Am J Neuroradiol 26 2005 770 776
7. A.G. Sorensen, T.T. Batchelor, and W.T. Zhang Response criteria for glioma Nat Clin Pract Oncol 5 2008 634 644
8. J.W. Henson, S. Ulmer, and G.J. Harris Brain tumor imaging in clinical trials Am J Neuroradiol 29 2008 419 424
9. D. Xue, and R.E. Albright Jr Preoperative anaplastic glioma tumor volume effects on patient survival J Surg Oncol 72 1999 199 205
10. G. Iliadis, P. Selviaridis, and A. Kalogera-Fountzila The importance of tumor volume in the prognosis of patients with glioblastoma: comparison of computerized volumetry and geometrical models Strahlenther Onkol 185 2009 743 750
11. L. Van Hoe, E. Van Cutsem, and I. Vergote Size quantification of liver metastases in patients undergoing cancer treatment: reproducibility of one-, two-, and three-dimensional measurements determined with spiral CT Radiology 202 1997 671 675
12. M.J. van den Bent, M.A. Vogelbaum, and P.Y. Wen End point assessment in gliomas: novel treatments limit usefulness of classical Macdonald's Criteria J Clin Oncol 27 2009 2905 2908
13. P.Y. Wen, D.R. Macdonald, and D.A. Reardon Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group J Clin Oncol 28 2010 1963 1972
14. C.J. Watling, D.H. Lee, D.R. Macdonald, and J.G. Cairncross Corticosteroid-induced magnetic resonance imaging changes in patients with recurrent malignant glioma J Clin Oncol 12 1994 1886 1889
15. M.A. Finn, D.T. Blumenthal, K.L. Salzman, and R.L. Jensen Transient postictal MRI changes in patients with brain tumors may mimic disease progression Surg Neurol 67 2007 246 250
16. S. Ulmer, T.A. Braga, F.G. Barker 2nd, M.H. Lev, R.G. Gonzalez, and J.W. Henson Clinical and radiographic features of peritumoral infarction following resection of glioblastoma Neurology 67 2006 1668 1670
17. A.J. Kumar, N.E. Leeds, and G.N. Fuller Malignant gliomas: MR imaging spectrum of radiation therapy- and chemotherapy-induced necrosis of the brain after treatment Radiology 217 2000 377 384
18. J. Shinoda, H. Yano, and H. Ando Radiological response and histological changes in malignant astrocytic tumors after stereotactic radiosurgery Brain Tumor Pathol 19 2002 83 92
19. D. Brandsma, L. Stalpers, and W. Taal Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas Lancet Oncol 9 2008 453 461
20. W. Taal, D. Brandsma, and H.G. de Bruin Incidence of early pseudo-progression in a cohort of malignant glioma patients treated with chemoirradiation with temozolomide Cancer 113 2008 405 410
21. A.A. Brandes, E. Franceschi, and A. Tosoni MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma patients J Clin Oncol 26 2008 2192 2197
22. J.L. Clarke, and S. Chang Pseudoprogression and pseudoresponse: challenges in brain tumor imaging Curr Neurol Neurosci Rep 9 2009 241 246
23. P.Y. Wen, and S. Kesari Malignant gliomas in adults N Engl J Med 359 2008 492 507
24. E.T. Wong, K.R. Hess, and M.J. Gleason Outcomes and prognostic factors in recurrent glioma patients enrolled onto phase II clinical trials J Clin Oncol 17 1999 2572 2578
25. M. Nowosielski, W. Recheis, and G. Goebel ADC histograms predict response to anti-angiogenic therapy in patients with recurrent high-grade glioma Neuroradiology 53 2011 291 302
26. W.B. Pope, J.R. Young, and B.M. Ellingson Advances in MRI assessment of gliomas and response to anti-VEGF therapy Curr Neurol Neurosci Rep 11 2011 336 344
27. W. Chen Clinical applications of PET in brain tumors J Nucl Med 48 2007 1468 1481
28. C. Tsien, C.J. Galbán, and T.L. Chenevert Parametric response map as an imaging biomarker to distinguish progression from pseudoprogression in high-grade glioma J Clin Oncol 28 2010 2293 2299
29. L.S. Hu, L.C. Baxter, and K.A. Smith Relative cerebral blood volume values to differentiate high-grade glioma recurrence from posttreatment radiation effect: direct correlation between image-guided tissue histopathology and localized dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging measurements AJNR Am J Neuroradiol 30 2009 552 558
30. R.N. Sawlani, J. Raizer, and S.W. Horowitz Glioblastoma: a method for predicting response to antiangiogenic chemotherapy by using MR perfusion imaging - pilot study Radiology 255 2010 622 628